{"id":"aspirin-continuation","safety":{"commonSideEffects":[{"rate":"null","effect":"Gastrointestinal bleeding"},{"rate":"null","effect":"Gastrointestinal upset"},{"rate":"null","effect":"Allergic reactions"}]},"_chembl":{"chemblId":"CHEMBL25","moleculeType":"Small molecule","molecularWeight":"180.16"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Aspirin continuation is a long-term treatment that continues the antiplatelet effects of aspirin, which is a nonsteroidal anti-inflammatory drug (NSAID). By inhibiting cyclooxygenase, aspirin continuation reduces the production of thromboxane A2, a potent stimulator of platelet aggregation, thereby decreasing the risk of blood clots and cardiovascular events.","oneSentence":"Aspirin continuation works by inhibiting the enzyme cyclooxygenase, which is involved in the production of prostaglandins and thromboxanes, leading to a decrease in platelet aggregation and blood clot formation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:02:45.268Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of cardiovascular events in patients with a history of myocardial infarction or stroke"}]},"trialDetails":[{"nctId":"NCT07496281","phase":"PHASE4","title":"OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2027-03-01","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent","enrollment":2},{"nctId":"NCT07052799","phase":"PHASE3","title":"Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2026-02-10","conditions":"Myocardial Infarction (MI), Cardiovascular Events, Post Polypectomy Bleeding in Antiplatelet Patients","enrollment":2514},{"nctId":"NCT06742931","phase":"NA","title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2025-04-07","conditions":"Chronic Coronary Syndrome","enrollment":1200},{"nctId":"NCT07240454","phase":"NA","title":"Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma","status":"RECRUITING","sponsor":"Tao Liu","startDate":"2025-10-15","conditions":"Chronic Subdural Hematoma","enrollment":143},{"nctId":"NCT06723145","phase":"PHASE4","title":"Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation","status":"RECRUITING","sponsor":"Kyoto University","startDate":"2025-01-20","conditions":"Antiplatelet Agents, Perioperative Care","enrollment":1200},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06111079","phase":"PHASE3","title":"Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia","status":"RECRUITING","sponsor":"FANG HE","startDate":"2023-11-01","conditions":"Preeclampsia, Perinatal Haemorrhage","enrollment":1800},{"nctId":"NCT06015477","phase":"NA","title":"Stent-Assisted Coiling Followed by Ticagrelor Monotherapy Instead of Dual Antiplatelet Therapy in Unruptured Intracranial Aneurysm","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-01-01","conditions":"Intracranial Aneurysm, Stent Complication","enrollment":180},{"nctId":"NCT05151796","phase":"","title":"Continuation of Aspirin Before Isolated Heart Valve Surgery","status":"UNKNOWN","sponsor":"University of Liege","startDate":"2012-05-01","conditions":"Isolated Heart Valve Surgery","enrollment":500},{"nctId":"NCT02350543","phase":"PHASE4","title":"Peri-operative Aspirin Continuation Versus Discontinuation","status":"TERMINATED","sponsor":"Rabin Medical Center","startDate":"2015-02","conditions":"Hematuria, Urinary Bladder Neoplasms","enrollment":50},{"nctId":"NCT02209909","phase":"NA","title":"Effects of Low Dose Aspirin Pre-treatment on Platelet Activation Undergoing Off-pump Coronary Artery Bypass Surgery","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-07","conditions":"Coronary Artery Disease","enrollment":48},{"nctId":"NCT00827411","phase":"PHASE4","title":"Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-01","conditions":"Coronary Artery Disease, Acute Coronary Syndrome","enrollment":2500},{"nctId":"NCT01470040","phase":"PHASE4","title":"Does Discontinuation of Aspirin Treatment Following Head Trauma Decrease the Incidence of Chronic Subdural Hematoma?","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2012-02","conditions":"Head Trauma, Traumatic Brain Injury, Chronic Subdural Hematoma","enrollment":100},{"nctId":"NCT01006083","phase":"","title":"Antiplatelet Therapy Continuation in Spine Surgery - Its Effect on Postoperative Morbidity and Mortality","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2010-01","conditions":"Hemorrhage, Cerebrovascular Accident, Myocardial Infarction","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":41,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Low-dose aspirin (< 100mg/day)","initiation of aspirin in early pregnancy"],"phase":"phase_3","status":"active","brandName":"aspirin continuation","genericName":"aspirin continuation","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aspirin continuation works by inhibiting the enzyme cyclooxygenase, which is involved in the production of prostaglandins and thromboxanes, leading to a decrease in platelet aggregation and blood clot formation. Used for Prevention of cardiovascular events in patients with a history of myocardial infarction or stroke.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}